ONCONOVA THERAPEUTICS 3 RSS Feed | Nachrichten - www.finanzen.netwww.finanzen.net bietet Finanznachrichten zum weltweiten BörsengeschehenFinanzenhttps://www.finanzen.netde-definanzen.net GmbHSat, 04 Apr 2026 09:37:30 +0200https://images.finanzen.net/images/finanzen_net_neu.gifONCONOVA THERAPEUTICS 3 RSS Feed | Nachrichten - www.finanzen.nethttps://www.finanzen.netChemDiv Extends CMC Services Collaboration for Ratutrelvir, a Potential Best-in-Class COVID-19 Therapeutic Advancing in Phase 2 Clinical TrialsThu, 30 Oct 2025 17:00:00 +0100https://www.finanzen.net/nachricht/aktien/chemdiv-extends-cmc-services-collaboration-for-ratutrelvir-a-potential-best-in-class-covid-19-therapeutic-advancing-in-phase-2-clinical-trials-15149645

SAN DIEGO, Oct. 30, 2025 /PRNewswire/ -- ChemDiv, a global provider of integrated drug discovery solutions, ...

]]>https://www.finanzen.net/nachricht/aktien/chemdiv-extends-cmc-services-collaboration-for-ratutrelvir-a-potential-best-in-class-covid-19-therapeutic-advancing-in-phase-2-clinical-trials-15149645Dover, Delaware -- Expert Systems Inc., a leading life sciences accelerator, Supports Traws Pharma Phase 2 Clinical Studies of Ratutrelvir -- a Novel Ritonavir-Free Antiviral for COVID-19.Thu, 23 Oct 2025 00:40:00 +0200https://www.finanzen.net/nachricht/aktien/dover-delaware-expert-systems-inc-a-leading-life-sciences-accelerator-supports-traws-pharma-phase-2-clinical-studies-of-ratutrelvir-a-novel-ritonavir-free-antiviral-for-covid-19-15108490

DOVER, Del., Oct. 22, 2025 /PRNewswire/ -- Expert Systems Inc., a leading life sciences accelerator, ...

]]>https://www.finanzen.net/nachricht/aktien/dover-delaware-expert-systems-inc-a-leading-life-sciences-accelerator-supports-traws-pharma-phase-2-clinical-studies-of-ratutrelvir-a-novel-ritonavir-free-antiviral-for-covid-19-15108490